Interpace Biosciences, Inc (IDXG) insider trading
Every open-market stock purchase and sale by Interpace Biosciences, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Thomas W. Burnell (CEO), $94.2K, 5 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent IDXG insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 20, 2026 | Thomas W. Burnell (CEO) | Sold (not open market) | $937K |
| Aug 20, 2026 | Thomas W. Burnell (CEO) | Bought (not open market) | — |
| Aug 20, 2026 | Thomas W. Burnell (CEO) | Bought (not open market) | — |
| Aug 20, 2026 | Thomas W. Burnell (CEO) | Bought (not open market) | — |
| Aug 20, 2026 | Fortunato R. Rocca (Director) | Bought (not open market) | — |
| Aug 20, 2026 | Vijay Aggarwal (Director) | Bought (not open market) | — |
| Aug 20, 2026 | Joseph D Keegan (Director) | Bought (not open market) | — |
| Aug 20, 2026 | Christopher McCarthy (CFO) | Bought (not open market) | — |
| Aug 20, 2026 | Christopher McCarthy (CFO) | Bought (not open market) | — |
| Aug 20, 2026 | Christopher McCarthy (CFO) | Bought (not open market) | — |
| Aug 20, 2026 | Christopher McCarthy (CFO) | Bought (not open market) | — |
| Aug 20, 2026 | Stephen J Sullivan (Director) | Bought (not open market) | — |
| Aug 20, 2026 | Thomas W. Burnell (CEO) | Bought (not open market) | — |
| Jan 20, 2026 | 2018 Limited Partnership Ampersand (10% owner) | Bought (not open market) | $28M |
| Jan 20, 2026 | 1315 Capital II L.P. (10% owner) | Bought (not open market) | $19M |
| Jan 20, 2026 | 1315 Capital II L.P. (10% owner) | Bought (not open market) | — |
| Jan 20, 2026 | 2018 Limited Partnership Ampersand (10% owner) | Bought (not open market) | — |
Who's trading IDXG
- Stephen J Sullivan, Director: other filings, last Aug 20, 2026
- Vijay Aggarwal, Director: other filings, last Aug 20, 2026
- Christopher McCarthy, CFO: other filings, last Aug 20, 2026
- Fortunato R. Rocca, Director: other filings, last Aug 20, 2026
- Thomas W. Burnell, CEO: other filings, last Aug 20, 2026
- Joseph D Keegan, Director: other filings, last Aug 20, 2026
- 2018 Limited Partnership Ampersand, 10% owner: other filings, last Jan 20, 2026
- 1315 Capital II L.P., 10% owner: other filings, last Jan 20, 2026
Get free alerts when an insider at Interpace Biosciences, Inc files a new trade →